Hanyang Med Rev.  2014 May;34(2):87-90. 10.7599/hmr.2014.34.2.87.

Association between Voiding Dysfunction and Depression

Affiliations
  • 1Department of Urology, Hanyang University College of Medicine, Seoul, Korea. moonuro@hanyang.ac.kr

Abstract

Depressive disorders have an overall incidence of 2-15%, and are among the most common mental illnesses. Depression is currently considered to be the fourth leading cause of premature death or disability, and it is expected to become the second leading cause of disease burden by 2020. It is closely related with the pathogenesis of many chronic diseases. Recently, some studies have shown the correlation of depressive disorders with lower urinary tract symptoms (LUTS) caused by benign prostatic hypertrophy, overactive bladder and other urological diseases. It is still unknown exactly what mechanism is the link between concomitant depression and LUTS, however differences in levels of antidiuretic hormone, inflammatory cytokines, phosphodiesterase isoenzyme and serotonin have been identified in patients suffering from depressive symptoms with LUTS. Numerous cross sectional studies and prospective cohort epidemiological investigations performed around the world have failed to demonstrate a clear causative mechanism for the relationship due to various limitations. Concomitant depression with LUTS creates a vicious cycle of suffering that significantly lowers the quality of life for patients. Further research is warranted to prevent progression of disease and improve the clinical outcome for patients with LUTS and associated depressive disorder.

Keyword

Depression; Lower Urinary Tract Symptoms; Socioeconomic Factors

MeSH Terms

Chronic Disease
Cohort Studies
Cytokines
Depression*
Depressive Disorder
Humans
Incidence
Lower Urinary Tract Symptoms
Mortality, Premature
Prostatic Hyperplasia
Quality of Life
Serotonin
Socioeconomic Factors
Urinary Bladder, Overactive
Urologic Diseases
Cytokines
Serotonin

Cited by  1 articles

The Relationship Between Mental Health and Physical Health
Bo Youl Choi
Hanyang Med Rev. 2014;34(2):51-52.    doi: 10.7599/hmr.2014.34.2.51.


Reference

1. Bertolote JM, Fleischmann A, De Leo D, Wasserman D. Psychiatric diagnoses and suicide: revisiting the evidence. Crisis. 2004; 25:147–155.
Article
2. Ayuso-Mateos JL, Vazquez-Barquero JL, Dowrick C, Lehtinen V, Dalgard OS, Casey P, et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry. 2001; 179:308–316.
Article
3. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62:593–602.
Article
4. Oh DH, Kim SA, Lee HY, Seo JY, Choi BY, Nam JH. Prevalence and correlates of depressive symptoms in korean adults: results of a 2009 korean community health survey. J Korean Med Sci. 2013; 28:128–135.
Article
5. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998; 4:1241–1243.
Article
6. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007; 370:851–858.
Article
7. Archer J, Hutchison I, Korszun A. Mood and malignancy: head and neck cancer and depression. J Oral Pathol Med. 2008; 37:255–270.
Article
8. Sobel RM, Markov D. The impact of anxiety and mood disorders on physical disease: the worried not-so-well. Curr Psychiatry Rep. 2005; 7:206–212.
Article
9. Lippi G, Montagnana M, Favaloro EJ, Franchini M. Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost. 2009; 35:325–336.
Article
10. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry. 2003; 54:269–282.
Article
11. Welch G, Weinger K, Barry MJ. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology. 2002; 59:245–250.
Article
12. Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int. 2009; 103:Suppl 3. 4–11.
Article
13. Asplund R, Johansson S, Henriksson S, Isacsson G. Nocturia, depression and antidepressant medication. BJU Int. 2005; 95:820–823.
Article
14. Asplund R, Aberg H. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med. 1991; 229:131–134.
Article
15. Asplund R, Henriksson S, Johansson S, Isacsson G. Nocturia and depression. BJU Int. 2004; 93:1253–1256.
Article
16. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009; 71:171–186.
Article
17. Taraz M, Khatami MR, Dashti-Khavidaki S, Akhonzadeh S, Noorbala AA, Ghaeli P, et al. Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial. Int Immunopharmacol. 2013; 17:917–923.
Article
18. Krogh J, Benros ME, Jorgensen MB, Vesterager L, Elfving B, Nordentoft M. The association between depressive symptoms, cognitive function, and inflammation in major depression. Brain Behav Immun. 2014; 35:70–76.
Article
19. Gandaglia G, Briganti A, Gontero P, Mondaini N, Novara G, Salonia A, et al. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int. 2013; 112:432–441.
Article
20. Kim SH, Jung KI, Koh JS, Min KO, Cho SY, Kim HW. Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi? Urol Int. 2013; 90:144–149.
Article
21. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009; 65:732–741.
Article
22. Wong ML, Whelan F, Deloukas P, Whittaker P, Delgado M, Cantor RM, et al. Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response. Proc Natl Acad Sci U S A. 2006; 103:15124–15129.
Article
23. Steers WD, Herschorn S, Kreder KJ, Moore K, Strohbehn K, Yalcin I, et al. Duloxetine compared with placebo for treating women with symptoms of overactive bladder. BJU Int. 2007; 100:337–345.
Article
24. Laumann EO, Kang JH, Glasser DB, Rosen RC, Carson CC. Lower urinary tract symptoms are associated with depressive symptoms in white, black and Hispanic men in the United States. J Urol. 2008; 180:233–240.
Article
25. Klausner AP, Steers WD. Corticotropin releasing factor: a mediator of emotional influences on bladder function. J Urol. 2004; 172:2570–2573.
Article
26. Wong SY, Hong A, Leung J, Kwok T, Leung PC, Woo J. Lower urinary tract symptoms and depressive symptoms in elderly men. J Affect Disord. 2006; 96:83–88.
Article
27. Fitzgerald M, Link C, Litman H, Travison T, McKinlay J. Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses. Eur Urol. 2007; 52:407–415.
Article
28. Johnson TV, Abbasi A, Ehrlich SS, Kleris RS, Chirumamilla SL, Schoenberg ED, et al. Major depression drives severity of American Urological Association Symptom Index. Urology. 2010; 76:1317–1320.
Article
29. Breyer BN, Kenfield SA, Blaschko SD, Erickson BA. The association of lower urinary tract symptoms, depression and suicidal ideation: data from the 2005-2006 and 2007-2008 national health and nutrition examination survey. J Urol. 2014; 191:1333–1339.
Article
30. Rom M, Schatzl G, Swietek N, Rucklinger E, Kratzik C. Lower urinary tract symptoms and depression. BJU Int. 2012; 110:E918–E921.
Article
31. Johnson TV, Abbasi A, Ehrlich SS, Kleris RS, Raison CL, Master VA. Nocturia associated with depressive symptoms. Urology. 2011; 77:183–186.
Article
32. Yu HJ, Chen TH, Chie WC, Liu CY, Tung TH, Huang SW. Prevalence and associated factors of nocturia among adult residents of the Matsu area of Taiwan. J Formos Med Assoc. 2005; 104:444–447.
33. Van Dijk L, Kooij DG, Schellevis FG. Nocturia in the Dutch adult population. BJU Int. 2002; 90:644–648.
Article
34. Asplund R. Mortality in the elderly in relation to nocturnal micturition. BJU Int. 1999; 84:297–301.
Article
35. Jennum P. Sleep and nocturia. BJU Int. 2002; 90:Suppl 3. 21–24.
Article
36. Hakkinen JT, Shiri R, Koskimaki J, Tammela TL, Auvinen A, Hakama M. Depressive symptoms increase the incidence of nocturia: Tampere Aging Male Urologic Study (TAMUS). J Urol. 2008; 179:1897–1901.
Article
37. Lee YI, Kim JW, Bae SR, Paick SH, Kim KW, Kim HG, et al. Effect of urgency symptoms on the risk of depression in community-dwelling elderly men. Korean J Urol. 2013; 54:762–766.
Article
38. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008; 101:1388–1395.
Article
Full Text Links
  • HMR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr